مباشر

FierceBiotechCreate Medicines fashions $122M fundraise for in vivo CAR-T dreams BioPharma DiveWith new data, Regenxbio to seek FDA approval of Duchenne gene therapy Endpoints NewsHow Penn Medicine plans to use AI to train their doctors FierceBiotechBiogen advances Alzheimer’s tau program despite midphase miss PharmaVoiceFDA chief’s exit clouds already murky drug approvals JEOLJEOL stock (JP3612800009): Medical equipment business sale to Sysmex marks strategic shift - AD HOC NEWS Endpoints NewsBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy FierceBiotechAptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development FierceBiotechRegenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy CellTransplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models Endpoints NewsRegenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval Endpoints NewsBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta

Cell ١٤ مايو ٢٠٢٦

Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models

Publication date: Available online 14 May 2026 Source: Cell Author(s): Shiwei Du, Qi Long, Yanshuang Zhou, Jiangqin Fu, Hao Wu, Liang Yang, Yaohang Xie, Yingzhe...

Publication date: Available online 14 May 2026 Source: Cell Author(s): Shiwei Du, Qi Long, Yanshuang Zhou, Jiangqin Fu, Hao Wu, Liang Yang, Yaohang Xie, Yingzhe Ding, Maolei Zhang, Jingyi Guo, Mengfei Wang, Jiajun Lin, Mingli Hu, Jian Zhang, Deyang Yao, Wei Li, Feixiang Bao, Ge Xiang, Yi Wu, Yile Huang